NOVARTIS AG (NVSEF)
Clinical trial NCT03945318 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-06-10 3. primary completion date: 2026-04-30 → 2026-06-10
Clinical trial NCT03945318 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-06-10 3. primary completion date: 2026-04-30 → 2026-06-10
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical